Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Abacavir | hsa00052 | Galactose metabolism | 1.06E-03 | 2 | P06280, O43451 | GLA, MGAM | More | | Abacavir | hsa00053 | Ascorbate and aldarate metabolism | 6.45E-05 | 1 | P14550 | AKR1A1 | More | | Abacavir | hsa00270 | Cysteine and methionine metabolism | 2.06E-02 | 2 | P26358, P48506 | DNMT1, GCLC | More | | Abacavir | hsa00440 | Phosphonate and phosphinate metabolism | 3.98E-02 | 1 | Q9Y6K0 | CEPT1 | More | | Abacavir | hsa00500 | Starch and sucrose metabolism | 2.32E-04 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Abacavir | hsa00561 | Glycerolipid metabolism | 1.41E-02 | 2 | P14550, Q86XP1 | AKR1A1, DGKH | More | | Abacavir | hsa00564 | Glycerophospholipid metabolism | 4.61E-02 | 2 | Q9Y6K0, Q86XP1 | CEPT1, DGKH | More | | Abacavir | hsa00565 | Ether lipid metabolism | 1.52E-03 | 2 | Q9Y6K0, Q8N661 | CEPT1, TMEM86B | More | | Abacavir | hsa00670 | One carbon pool by folate | 3.15E-02 | 2 | O95954, Q99707 | FTCD, MTR | More | | Abacavir | hsa00730 | Thiamine metabolism | 2.53E-04 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Abacavir | hsa00860 | Porphyrin and chlorophyll metabolism | 3.15E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Abacavir | hsa00983 | Drug metabolism - other enzymes | 4.76E-04 | 4 | P20839, P32320, P05164, Q16772 | IMPDH1, CDA, MPO, GSTA3 | More | | Abacavir | hsa01100 | Metabolic pathways | 5.92E-03 | 10 | Q9Y234, Q16772, P20839, O94777, Q9Y6K0, Q86XP1, P14550, Q9UHK6, Q86VZ5, Q9NVH6 | LIPT1, GSTA3, IMPDH1, DPM2, CEPT1, DGKH, AKR1A1, AMACR, SGMS1, TMLHE | More | | Abacavir | hsa01524 | Platinum drug resistance | 2.82E-02 | 2 | Q16772, P07992 | GSTA3, ERCC1 | More | | Abacavir | hsa03010 | Ribosome | 1.88E-02 | 6 | P62753, P25398, P32969, P62829, P18077, P36578 | RPS6, RPS12, RPL9, RPL23, RPL35A, RPL4 | More | | Abacavir | hsa03013 | RNA transport | 7.52E-05 | 11 | O14980, Q09161, P61326, Q9H307, Q7Z3B4, P35658, Q14152, O75822, Q14240, Q06787, P51114 | XPO1, NCBP1, MAGOH, PNN, NUP54, NUP214, EIF3A, EIF3J, EIF4A2, FMR1, FXR1 | More | | Abacavir | hsa03020 | RNA polymerase | 3.59E-02 | 2 | P30876, P62487 | POLR2B, POLR2G | More | | Abacavir | hsa03460 | Fanconi anemia pathway | 2.07E-02 | 2 | Q9BXW9, P07992 | FANCD2, ERCC1 | More | | Abacavir | hsa04071 | Sphingolipid signaling pathway | 1.94E-02 | 3 | Q9H228, P01375, Q9UQC2 | EDG8, TNF, GAB2 | More | | Abacavir | hsa04120 | Ubiquitin mediated proteolysis | 7.13E-03 | 4 | Q14145, Q13042, P61088, Q15751 | KEAP1, CDC16, UBE2N, HERC1 | More | | Abacavir | hsa04141 | Protein processing in endoplasmic reticulum | 4.88E-02 | 4 | P18848, O60337, P11142, P07900 | ATF4, MARH6, HSPA8, HSP90AA1 | More | | Abacavir | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | | Abacavir | hsa04217 | Necroptosis | 4.42E-04 | 6 | P07900, P15104, P05141, P01584, P0C0S5, Q13557 | HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, CAMK2D | More | | Abacavir | hsa04310 | Wnt signaling pathway | 1.79E-02 | 2 | P17612, P67870 | PRKACA, CSNK2B | More | | Abacavir | hsa04340 | Hedgehog signaling pathway | 2.36E-03 | 3 | P49841, P17612, P22694 | GSK3B, PRKACA, PRKACB | More | | Abacavir | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | | Abacavir | hsa04611 | Platelet activation | 2.12E-02 | 2 | Q9Y490, P17612 | TLN1, PRKACA | More | | Abacavir | hsa04612 | Antigen processing and presentation | 3.74E-05 | 4 | P61769, P01889, P10321, Q06323 | B2M, HLA-B, HLA-C, PSME1 | More | | Abacavir | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | | Abacavir | hsa04650 | Natural killer cell mediated cytotoxicity | 4.37E-04 | 3 | Q29983, P10321, P01889 | MICA, HLA-C, HLA-B | More | | Abacavir | hsa04657 | IL-17 signaling pathway | 1.42E-04 | 7 | P07900, O00463, Q16539, P49841, P14780, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, MMP9, TNF, IL1B | More | | Abacavir | hsa04664 | Fc epsilon RI signaling pathway | 3.98E-02 | 3 | P01375, Q16539, Q9UQC2 | TNF, MAPK14, GAB2 | More | | Abacavir | hsa04668 | TNF signaling pathway | 2.21E-02 | 5 | P01375, O00463, Q16539, P20749, P14780 | TNF, TRAF5, MAPK14, BCL3, MMP9 | More | | Abacavir | hsa04742 | Taste transduction | 3.91E-02 | 1 | P17612 | PRKACA | More | | Abacavir | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Abacavir | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Abacavir | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Abacavir | hsa04932 | Non-alcoholic fatty liver disease | 9.70E-03 | 4 | P18848, P01584, P13073, O15239 | ATF4, IL1B, COX4I1, NDUFA1 | More | | Abacavir | hsa04940 | Type I diabetes mellitus | 5.03E-03 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Abacavir | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Abacavir | hsa05012 | Parkinson disease | 2.53E-02 | 5 | O15239, P13073, P05141, P18848, Q13557 | NDUFA1, COX4I1, SLC25A5, ATF4, CAMK2D | More | | Abacavir | hsa05016 | Huntington disease | 3.21E-02 | 5 | O15239, P13073, P30876, P62487, P05141 | NDUFA1, COX4I1, POLR2B, POLR2G, SLC25A5 | More | | Abacavir | hsa05020 | Prion disease | 3.37E-03 | 7 | P13591, P01584, P11142, O15239, P13073, P18848, P05141 | NCAM1, IL1B, HSPA8, NDUFA1, COX4I1, ATF4, SLC25A5 | More | | Abacavir | hsa05022 | Pathways of neurodegeneration - multiple diseases | 3.80E-02 | 6 | O15239, P13073, P18848, P05141, P01584, Q13557 | NDUFA1, COX4I1, ATF4, SLC25A5, IL1B, CAMK2D | More | | Abacavir | hsa05110 | Vibrio cholerae infection | 2.11E-03 | 2 | Q99437, P17612 | ATP6V0B, PRKACA | More | | Abacavir | hsa05134 | Legionellosis | 1.28E-02 | 3 | P01584, P68104, P11142 | IL1B, EEF1A1, HSPA8 | More | | Abacavir | hsa05160 | Hepatitis C | 2.06E-02 | 3 | P52630, P60033, Q9NZJ5 | STAT2, CD81, EIF2AK3 | More | | Abacavir | hsa05162 | Measles | 4.02E-02 | 3 | P11142, P01584, Q9NP90 | HSPA8, IL1B, RAB9B | More | | Abacavir | hsa05163 | Human cytomegalovirus infection | 2.80E-02 | 6 | P01375, P49841, P14778, P25025, Q16539, O00463 | TNF, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5 | More | | Abacavir | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 4.67E-03 | 3 | P01889, P10321, Q29983 | HLA-B, HLA-C, MICA | More | | Abacavir | hsa05168 | Herpes simplex virus 1 infection | 2.40E-02 | 7 | P01568, Q07955, Q13243, Q13489, P30101, Q13398, O75820 | IFNA21, SFRS1, SFRS5, BIRC3, PDIA3, ZNF211, ZNF189 | More | | Abacavir | hsa05170 | Human immunodeficiency virus 1 infection | 3.66E-04 | 4 | P01889, P10321, P61769, Q9NQU5 | HLA-B, HLA-C, B2M, PAK6 | More | | Abacavir | hsa05171 | Coronavirus disease - COVID-19 | 9.72E-03 | 7 | P01584, P62753, P25398, P36578, P32969, P18077, P62829 | IL1B, RPS6, RPS12, RPL4, RPL9, RPL35A, RPL23 | More | | Abacavir | hsa05203 | Viral carcinogenesis | 3.58E-03 | 3 | P06396, P01889, P10321 | GSN, HLA-B, HLA-C | More | | Abacavir | hsa05222 | Small cell lung cancer | 1.29E-02 | 4 | P10826, Q13751, Q13489, O75293 | RARB, LAMB3, BIRC3, GADD45B | More | | Abacavir | hsa05320 | Autoimmune thyroid disease | 3.18E-03 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Abacavir | hsa05330 | Allograft rejection | 3.18E-03 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Abacavir | hsa05332 | Graft-versus-host disease | 5.03E-03 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Abacavir | hsa05415 | Diabetic cardiomyopathy | 2.87E-02 | 4 | P05141, O15239, P13073, Q13557 | SLC25A5, NDUFA1, COX4I1, CAMK2D | More | | Abacavir | hsa05418 | Fluid shear stress and atherosclerosis | 1.08E-03 | 7 | Q16539, Q14145, P10599, P14780, P01375, P14778, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, IL1R1, IL1R2 | More | | |